MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 97 filers reported holding MAGENTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,000 | -40.0% | 2,148 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | -75.0% | 2,148 | -65.8% | 0.00% | – |
| Q2 2021 | $60,000 | -85.5% | 6,289 | -82.1% | 0.00% | -100.0% |
| Q1 2021 | $414,000 | -32.6% | 35,039 | -55.4% | 0.00% | 0.0% |
| Q4 2020 | $614,000 | +1.0% | 78,560 | -12.5% | 0.00% | 0.0% |
| Q3 2020 | $608,000 | +84.2% | 89,756 | +103.4% | 0.00% | 0.0% |
| Q2 2020 | $330,000 | +22.2% | 44,123 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $270,000 | -4.3% | 42,767 | +129.1% | 0.00% | 0.0% |
| Q4 2019 | $282,000 | -55.3% | 18,668 | -69.7% | 0.00% | 0.0% |
| Q3 2019 | $631,000 | – | 61,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $8,110,000 | 5.33% |
| TCG Crossover Management, LLC | 2,124,122 | $2,549,000 | 1.08% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $4,172,000 | 0.70% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 295,000 | $354,000 | 0.48% |
| Deep Track Capital, LP | 5,359,000 | $6,431,000 | 0.42% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $1,404,000 | 0.34% |
| Casdin Capital, LLC | 2,415,000 | $2,898,000 | 0.24% |
| Alphabet Inc. | 3,339,138 | $4,007,000 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 159,307 | $191,000 | 0.14% |
| Bleichroeder LP | 484,400 | $581,000 | 0.12% |